Hormonal and metabolic functions of the small intestine;Hormonale und metabolische Funktionen des Dünndarms

Internist

Volumn 51, Issue 6, 2010, Pages 695-701

  Wittenburg, H ^a   Tennert, U ^a   Mossner J ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Energy balance; Gallbladder motility; Ghrelin; Satiation hormone; Small intestine

Indexed keywords

CHOLECYSTOKININ; FIBROBLAST GROWTH FACTOR; GHRELIN; GLUCAGON LIKE PEPTIDE; PANCREAS ENZYME; PEPTIDE YY;

BILE ACID SYNTHESIS; ENERGY BALANCE; ENTEROENDOCRINE CELL; FATTY ACID SYNTHESIS; GALLBLADDER MOTILITY; HORMONAL REGULATION; HUMAN; INTESTINE FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; SATIETY;

GHRELIN; HORMONES; HUMANS; INTESTINAL DISEASES; INTESTINAL MUCOSA; INTESTINE, SMALL; MODELS, BIOLOGICAL;

EID: 77955094150     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-009-2564-y     Document Type: Review

References (29)

1. Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132: 2131-2157.
2. Bhatnagar S, Damron HA, Hillgartner FB (2009) Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis. J Biol Chem 284: 10023-10033.
3. Choi M, Moschetta A, Bookout al. et al. (2006) Identification of a hormonal basis for gallbladder filling. Nat Med 12: 1253-1255.
4. Crawley JN, Beinfeld MC (1983) Rapid development of tolerance to the behavioural actions of cholecystokinin. Nature 302: 703-706.
5. Cummings DE, Overduin J (2007) Gastrointestinal regulation of food intake. J Clin Invest 117: 13-23.
6. Cummings DE, Weigle DS, Frayo RS et al. (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346: 1623-1630.
7. Dueland S, Reichen J, Everson GT et al. (1991) Regulation of cholesterol and bile acid homoeostasis in bile-obstructed rats. Biochem J 280: 373-377.
8. Fu L, John LM, Adams SH et al. (2004) Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 145: 2594-2603.
9. Giralt M, Vergara P (1999) Glucagonlike peptide-1 (GLP-1) participation in ileal brake induced by intraluminal peptones in rat. Dig Dis Sci 44: 322-329.
10. Grider JR (1994) Role of cholecystokinin in the regulation of gastrointestinal motility. J Nutr 124: 1334S-1339S.
11. Inagaki T, Choi M, Moschetta A et al. (2005) Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2: 217-225.
12. Kissileff HR, Carretta JC, Geliebter A et al. (2003) Cholecystokinin and stomach distension combine to reduce food intake in humans. Am J Physiol Regul Integr Comp Physiol 285: R992-998.
13. Masclee AA, Vu MK (2003) Gallbladder motility in inflammatory bowel diseases. Dig Liver Dis 35 (Suppl 3): S35-38.
14. Moran TH, Kinzig KP (2004) Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol 286: G183-188.
15. Moschetta A, Stolk MF, Rehfeld JF et al. (2001) Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR. Aliment Pharmacol Ther 15: 181-185.
16. Murphy KG, Dhillo WS, Bloom SR (2006) Gut peptides in the regulation of food intake and energy homeostasis. Endocr Rev 27: 719-727.
17. Pandak WM, Heuman DM, Hylemon PB et al. (1995) Failure of intravenous infusion of taurocholate to down-regulate cholesterol 7 alpha-hydroxylase in rats with biliary fistulas. Gastroenterology 108: 533-544.
18. Pironi L, Stanghellini V, Miglioli M et al. (1993) Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology 105: 733-739.
19. Qualmann C, Nauck MA, Holst JJ et al. (1995) Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose). Scand J Gastroenterol 30: 892-896.
20. Schaap FG, Gaag NA van der, Gouma DJ et al. (2009) High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis. Hepatology 49: 1228-1235.
21. Schreuder TC, Marsman HA, Lenicek M et al. (2010 The hepatic response to FGF19 is impaired in patients with non-alcoholic fatty liver disease and insulin resistance. Am J Physiol Gastrointest Liver Physiol 298: G440-445.
22. Shaffer EA (2000) Review article: control of gall-bladder motor function. Aliment Pharmacol Ther 14 (Suppl 2): 2-8.
23. Shaffer EA (2006) Gallstone disease: Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 20: 981-996.
24. Shin DJ, Osborne TF (2009) FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action. J Biol Chem 284: 11110-11120.
25. Strader AD, Woods SC (2005) Gastrointestinal hormones and food intake. Gastroenterology 128: 175-191.
26. Tschop M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407: 908-913.
27. Vincent RP, le Roux CW (2008) The satiety hormone peptide YY as a regulator of appetite. J Clin Pathol 61: 548-552.
28. Wang PY, Caspi L, Lam CK et al. (2008) Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature 452: 1012-1016.
29. Wren AM, Seal LJ, Cohen MA et al. (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86: 5992.